Progenitor gene DLK1 might be an independent prognostic factor of liver cancer

Expert Opinion on Biological Therapy

Volumn 8, Issue 4, 2008, Pages 371-377

  Jin, Zhong Hui ^a   Yang, Ren Jie ^a   Dong, Bin ^a   Xing, Bao Cai ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

DLK1; Liver cancer; Progenitor; Prognostic

Indexed keywords

ALPHA FETOPROTEIN; DLK1 PROTEIN, HUMAN; MEMBRANE PROTEIN; SIGNAL PEPTIDE; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DELTA LIKE 1 HOMOLOG GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CANCER; MAJOR CLINICAL STUDY; MARKER GENE; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; WESTERN BLOTTING; BILE DUCT CARCINOMA; BILE DUCT TUMOR; CANCER STEM CELL; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; INTRAHEPATIC BILE DUCT; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASTIC STEM CELLS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 42149148088     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.8.4.371     Document Type: Article

References (21)

1. Lee JS, Heo J, Libbrecht L, et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 2006;12(4):410-6
2. Fausto N, Campbell JS. The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 2003;120:117-30
3. Shiojiri N, Lemire JM, Fausto N. Cell lineages and oval cell progenitors in rat liver development. Cancer Res 1991;51:2611-20
4. Dumble ML, Croager EJ, Yeoh GC, Quail EA. Generation and characterization of p53 null transformed hepatic progenitor cells: oval cells give rise to hepatocellular carcinoma. Carcinogenesis 2002;23:435-45 • This study confirmed that the progenitor cells can develop into cancer.
5. Laborda J, Sausville EA, Hoffman T, Notario V. Dlk, a putative mammalian homeotic gene differentially expressed in small cell lung carcinoma and neuroendocrine tumor cell line. J Biol Chem 1993;268:3817-20
6. Yevtodiyenko A, Schmidt JV. Dlk1 expression marks developing endothelium and sites of branching morphogenesis in the mouse embryo and placenta. Dev Dyn 2006;235:1115-23
7. Suzuki A, Zheng YW, Kaneko S, et al. Clonal identification and characterization of self renewing pluripotent stem cells in the developing liver. J Cell Biol 2002;156:173-84 • This study confirms that DLK1 is a marker of liver progenitor cells.
8. Kubota H, Reid LM. Clonogenic hepatoblasts, common precursors for hepatocytic and biliary lineages, are lacking classical major histocompatibility complex class I antigen. Proc Natl Acad Sci USA 2000;97:12132-7
9. - hepatic cell progenitors of 11-day postcoitus mouse embryo liver reconstitutes cell-depleted liver organoids. J Clin Investig 2003;112:1152-63
10. Suzuki A, Zheng Y, Kondo R, et al. Flow-cytometric separation and enrichment of hepatic progenitor cells in the developing mouse liver. Hepatology 2000;32:1230-9
11. Tanimizu N, Nishikawa M, Saito H, et al. Isolation of hepatoblasts based on the expression of Dlk/Pref-1. J Cell Sci 2003;116:1775-86 • This study also confirms that DLK1 is an important marker of liver progenitor cells.
12. Nierhoff D, Ogawa A, Oertel M, et al. Purification and characterization of mouse fetal liver epithelial cells with high in vivo repopulation capacity. Hepatology 2005;42:130-9 • This study confirms that cells expressed DLK1 in fetal liver are liver progenitor cells.
13. Kawakami T, Chano T, Minami K, et al. Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma. Hum Mol Genet 2006;15:821-30
14. Baladron V, Ruiz-Hidalgo MJ, Bonivi E, et al. The EGF-like homeotic protein dlk affects cell growth and interacts with growth-modulating molecules in the yeast two-hybrid system. Biochem Biophys Res Commun 2002;291:193-204
15. Huang J, Zhang X, Zhang M, et al. Up-regulation of DLK1 as an imprinted gene could contribute to human hepatocellular carcinoma. Carcinogenesis 2007;28:1094-103
16. Yin D, Xie D, Sakajiri S, et al. DLK1: increased expression in gliomas and associated with oncogenic activities. Oncogene 2006;25:1852-61
17. Papaioannou VE, McBurney MW, Gardner RL, Evans MJ. Fate of teratocarcinoma cells injected into early mouse embryos. Nature 1975;258:70-3
18. Ausubel FM, Kingston RE, Seidman JG, et al. Short protocols in Molecular Biology. 4th edition. Hoboken, New Jersey; John Wiley & Son's, Inc.; 1999
19. Harlow E, Lane D. Using Antibodies: A Laboratory Manual. New York; Cold Spring Harbor Laboratory Press; 1999
20. Schmidt JV, Matteson PG, Jones BK, et al. The Dlk1 and Gtl2 genes are linked and reciprocally imprinted. Genes Dev 2000;14:1997-2002
21. Available from: http://www.genecards.com [last accessed March 6, 2008]